GBS GBS
$ 0.47
-0.57%
Quarterly report 2024-Q3
added 11-07-2024
Country |
USA |
IPO year |
2020 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Harry Simeonidis |
Employees in the company |
7 |
Shares |
1.59 M |
Market Cap[1] |
$ 7.12 M |
EBITDA (LTM) |
$ -9.1 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.